Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Early induction of insulin sensitisation treated by tirzepatide: a prospective, single-arm, open-label study in Japanese individuals with obesity and type 2 diabetes
Yuan A, Woo SB
Key drivers behind GLP-1 and addiction research include: Rapid expansion in the use of GLP-1 medications such as semaglutide (Ozempic and Wegovy) and tirzepatide (Maunjaro and Zepbound) Reports of changes in cravings, alcohol use, or reward-seeking behaviors beyond weight loss Increased public conversation and clinical curiosity about psychological and behavioral effects Scientific interest in GLP-1 activity within reward pathways and dopamine signaling Recognition that appetite regulation and addiction involve shared neural mechanisms This research is still emerging, and findings should be interpreted with caution
Unlike dual agonists such as tirzepatide, retatrutide adds glucagon receptor activation
p25 induces the hyperactivation of cyclin-dependent kinase 5 and disrupts GSK3-mediated processes [67]
US$ 20.32
US$ 22.94
US$ 25.62
US$ 28.44
US$ 23.17
